Regression of A549 lung cancer tumors by anti-miR-150 vector

Oncology Reports

Volumn 27, Issue 1, 2012, Pages 129-134

  Li, You Jie ^a   Zhang, Yan Xia ^a   Wang, Ping Yu ^a   Chi, Yong Liang ^b   Zhang, Chao ^a   Ma, Ying ^a   Lv, Chang Jun ^c   Xie, Shu Yang ^a  

^a Binzhou Medical University   (China)

^b Shandong China Traditional Medical Affiliated Hospital   (China)

^c BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Antisense oligonucleotides; Cancer therapy; Cell proliferation; microRNAs

Indexed keywords

ANTISENSE MICRORNA OLIGONUCLEOTIDE 150; ANTISENSE OLIGONUCLEOTIDE; MICRORNA; PROTEIN P53; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ANTISENSE THERAPY; ANTISENSE VECTOR; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; EXPRESSION VECTOR; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION TERMINATION; TRANSIENT TRANSFECTION; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; MICRORNAS; OLIGORIBONUCLEOTIDES, ANTISENSE; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84855289901     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1466     Document Type: Article

References (37)

1. Friedman RC, Farh KK, Burge CB and Bartel DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105, 2009.
2. Ambros V: MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113: 673-676, 2003.
3. Garzon R, Calin GA and Croce CM: microRNAs in cancer. Annu Rev Med 60: 167-179, 2009.
4. Garzon R, Fabbri M, Cimmino A, Calin GA and Croce CM: MicroRNA expression and function in cancer. Trends Mol Med 12: 580-587, 2006. (Pubitemid 44780201)
5. Tong AW and Nemunaitis J: Modulation of microRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther 15: 341-355, 2008. (Pubitemid 351693228)
6. Garzon R, Liu S, Fabbri M, et al.: MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113: 6411-6418, 2009.
7. Marcucci G, Maharry K, Radmacher MD, et al.: Prognostic signifcance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. J Clin Oncol 26: 5078-5087, 2008.
8. Bueno MJ, Perez de Castro I, Gomez de Cedron M, et al.: Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13: 496-506, 2008. (Pubitemid 351763902)
9. Eiring AM, Harb JG, Neviani P, et al.: miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 140: 652-665, 2010.
10. Venturini L, Battmer K, Castoldi M, et al.: Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 109: 4399-4405, 2007. (Pubitemid 46743409)
11. Bandi N and Vassella E: miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner. Mol Cancer 10: 55, 2011.
12. Jeong HC, Kim EK, Lee JH, Yoo HN and Kim JK: Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients. Mol Med Rep 4: 383-387, 2011.
13. Garcia AI, Buisson M, Bertrand P, Rimokh R, Rouleau E, Lopez BS, Lidereau R, Mikaélian I and Mazoyer S: Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. EMBO Mol Med 3: 279-290, 2011.
14. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E and Grazi GL: Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67: 6092-6099, 2007. (Pubitemid 47037488)
15. Gramantieri L, Fornari F, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Croce CM, Bolondi L and Negrini M: MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res 15: 5073-5081, 2009.
16. Favaro E, Ramachandran A, McCormick R, Gee H, Blancher C, Crosby M, Devlin C, Blick C, Buffa F and Li JL: MicroRNA-210 regulates mitochondrial free radical response to hypoxia and Krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS One 5: e10345, 2010.
17. Cascio S, D'Andrea A, Ferla R, Surmacz E, Gulotta E, Amodeo V, Bazan V, Gebbia N and Russo A: miR-20b modulates VEGF expression by targeting HIF-1α and STAT3 in MCF-7 breast cancer cells. J Cell Physiol 224: 242-249, 2010.
18. Weiler J, Hunziker J and Hall J: Anti-microRNA oligonucleotides (AMOs): ammunition to target microRNAs implicated in human disease? Gene Ther 13: 496-502, 2006.
19. Baker BF, Lot SS, Condon TP, Cheng-Flournoy S, Lesnik EA, Sasmor HM and Bennett CF: 2′-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J Biol Chem 272: 11994-12000, 1997. (Pubitemid 27202775)
20. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M and McKay R: miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3: 87-98, 2006.
21. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C and Ferracin M: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006. (Pubitemid 43271657)
22. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M and Campiglio M: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005. (Pubitemid 41161233)
23. Lu Y, Xiao J, Lin H, Bai Y, Luo X, Wang Z and Yang B: A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference. Nucleic Acids Res 37: e24, 2009.
24. Fei J, Lan F, Guo M, Li Y and Liu Y: Inhibitory effects of anti-miRNA oligonucleotides (AMOs) on A549 cell growth. J Drug Target 16: 688-693, 2008.
25. Wang PY, Li YJ, Zhang S, Li ZL, Yue Z, Xie N and Xie SY: Regulating A549 cells growth by ASO inhibiting miRNA expression. Mol Cell Biochem 339: 163-171, 2010.
26. Xie SY, Zhang JZ, Huang SZ, Sun D, Ren ZR and Zeng YT: Suppression of eGFP expression in erythroid-specific transgenic mice by siRNA. Blood Cells Mol Dis 34: 220-225, 2005. (Pubitemid 40693558)
27. Ren H, Tian L, Gu Q and Zhu W: Secalonic acid D: a cytotoxic constituent from marine lichen-derived fungus Gliocladium sp. T31. Arch Pharm Res 29: 59-63, 2006. (Pubitemid 43268424)
28. O'Donovan DJ, Katkin JP, Tamura T, Smith CV and Welty SE: Attenuation of hyperoxia-induced growth inhibition in H441 cells by gene transfer of mitochondrially targeted glutathione reductase. Am J Respir Cell Mol Biol 22: 732-738, 2000. (Pubitemid 30400253)
29. Budhu A, Ji J and Wang XW: The clinical potential of microRNAs. J Hematol Oncol 3: 37, 2010.
30. Chang TC, Wentzel EA, Kent OA, et al.: Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745-752, 2007. (Pubitemid 46856245)
31. Buscaglia LE and Li Y: Apoptosis and the target genes of microRNA-21. Chin J Cancer 30: 371-380, 2011.
32. Wu N, Liu X, Xu X, Fan X, Liu M, Li X, Zhong Q and Tang H: MicroRNA-373, a new regulator of 6, functions as an oncogene in hepatocellular protein phosphatase carcinoma. FEBS J: April 11, 2011 (Epub ahead of print), doi: 10.1111/j.1742-4658. 2011.08120.x.
33. Zhou L, Qi X, Potashkin JA, Abdul-Karim FW and Gorodeski GI: MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3′-untranslated region of the gene that decrease steady-state levels of the transcript. J Biol Chem 283: 28274-28286, 2008.
34. Magrelli A, Azzalin G, Salvatore M, Viganotti M, Tosto F, Colombo T, Devito R, Di Masi A, Antoccia A, Lorenzetti S, Maranghi F, Mantovani A, Tanzarella C, Macino G and Taruscio D: Altered microRNA expression patterns in hepatoblastoma patients. Transl Oncol 2: 157-163, 2009.
35. Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K, Ren G, Su T, Pan Y, Feng B, Xue Z, Wang X and Fan D: MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun 392: 340-345, 2010.
36. Lin M, Chen W, Huang J, Gao H, Ye Y, Song Z and Shen X: MicroRNA expression profiles in human colorectal cancers with liver metastases. Oncol Rep 25: 739-747, 2010.
37. Meister G, Landthaler M, Dorsett Y and Tuschl T: Sequence specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10: 544-550, 2004. (Pubitemid 38241013)